December 4, 2020

Metformin and Risk of Mortality in Patients Hospitalised with COVID-19: A Retrospective Cohort Analysis

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

Keywords (Tags): diabetes, treatment

• Metformin was associated with significantly reduced mortality among women with obesity or type 2 diabetes who were hospitalized with COVID-19, according to a retrospective cohort analysis using de-identified claims data (HR=0.79, 95%CI 0.65–0.95). Metformin use was not associated with a reduction in mortality among men in the study.

Bramante et al. (Dec 3, 2020). Metformin and Risk of Mortality in Patients Hospitalised with COVID-19: A Retrospective Cohort Analysis. The Lancet Healthy Longevity. https://doi.org/10.1016/S2666-7568(20)30033-7